Treatment of Parkinson’s disease (as monotherapy or combination therapy with L-DOPA's drugs).
Is to be administered by mouth, with or without a meal, at a dose of 1 mg once per day, both in monotherapy and in combination with
Dosage modification in elderly patients is not required.
The administration of rasagiline in patients with liver failure degree from moderate to severe is contraindicated.
Administering rasagiline in patients with mild hepatic insufficiency requires due caution. If progression of liver failure to a moderate degree is noted during the treatment with rasagiline, the use of the drug should be discontinued.
In patients with renal failure dosage moderation is not required.
3 years. Prohibited to use after expiry date.
Store at a temperature below +25°С. Keep out of reach of children.
Terms of sale